{"organizations": [], "uuid": "6d37ebe37f34e7bb1666eb2fb9b0e2d73cfb238c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180220.html", "section_title": "Archive News &amp; Video for Tuesday, 20 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-heat-biologics-gets-recommendation/brief-heat-biologics-gets-recommendation-to-continue-patient-enrollment-of-ongoing-phase-2-clinical-trial-idUSFWN1QA118", "country": "US", "domain_rank": 408, "title": "BRIEF-Heat Biologics Gets Recommendation To Continue Patient Enrollment Of Ongoing Phase 2 Clinical Trial", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.217, "site_type": "news", "published": "2018-02-21T03:00:00.000+02:00", "replies_count": 0, "uuid": "6d37ebe37f34e7bb1666eb2fb9b0e2d73cfb238c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-heat-biologics-gets-recommendation/brief-heat-biologics-gets-recommendation-to-continue-patient-enrollment-of-ongoing-phase-2-clinical-trial-idUSFWN1QA118", "ord_in_thread": 0, "title": "BRIEF-Heat Biologics Gets Recommendation To Continue Patient Enrollment Of Ongoing Phase 2 Clinical Trial", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - heat biologics inc", "sentiment": "neutral"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 20 (Reuters) - Heat Biologics Inc:\n* SAYS GOT INDEPENDENT DMC RECOMMENDATION TO CONTINUE PATIENT ENROLLMENT OF ONGOING PHASE 2 CLINICAL TRIAL FOR HS-110 AND NIVOLUMABâ€‹ Source text: ( bit.ly/2BG2kXt ) Further company coverage:\n ", "external_links": ["http://bit.ly/2BG2kXt", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-21T03:00:00.000+02:00", "crawled": "2018-02-21T21:43:55.061+02:00", "highlightTitle": ""}